...the combined company, which will be called MedCell Bioscience Ltd. and be located in Cambridge. NovaThera’s...
...that stimulates cell growth, is in preclinical development for wound care and tissue regeneration applications. NovaThera...
...$59 million). MedCell was advised by Innovator Capital Ltd. MedCell Bioscience Ltd. , London, U.K. NovaThera Ltd....

...The companies will evaluate NovaThera's automated stem cell expansion and delivery technologies and Gamida Cell's StemEx...
...technology to design and develop stem cell therapies to treat lung diseases, such as emphysema. NovaThera...
...at a later date. Financial terms were not disclosed. Gamida Cell Ltd. , Jerusalem, Israel NovaThera Ltd....

...NovaThera's NovaThera (Asia) Ltd. subsidiary and a consortium of partners including the university formed a joint...
...services in China and in the Association of Southeast Asian Nations (ASEAN). SteMing will use NovaThera's...
...to access all platform technologies and regenerative products developed by NovaThera for the ASEAN region. NovaThera Ltd....

...companies will jointly pursue commercial applications resulting from the deal. Cellartis AB , Gothenburg, Sweden NovaThera Ltd....

...to create tissue repair products using its recombinant proteins in combination with biomaterials developed by NovaThera Ltd....

...The companies will combine NovaThera's biomaterials with PHARM's recombinant proteins for potential use in tissue engineering...
...commercial rights to resulting products and IP, and NovaThera is eligible for milestones and royalties. NovaThera Ltd....